Trimetazidine Modified Release in the Treatment of Stable Angina: TRIUMPH Study1

Author： Vladimir I. Makolkin   Konstantin K. Osadchiy  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.12, 2004-01, pp. : 731-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Stable Angina Pectoris with Trimetazidine Modified Release in Indian Primary-Care Practice

By Gupta Rajeev  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 5, 2005-01 ,pp. : 325-329

Adis International

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Modified-Release Formulation of Trimetazidine for Exceptional Control of Angina Pectoris: Fact or Fiction

By Thadani Udho  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 5, 2005-01 ,pp. : 331-334

Adis International

Access to resources Recommend Favorite

Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris: A Sub-Study from TRIMPOL-1 (Trimetazidine in Poland)

By Kowalisko A.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 1, 2007-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite